"Supreme Court's Impact on Abortion Medication Rules Under Scrutiny"

The Supreme Court appears likely to uphold access to the abortion medication mifepristone, with a consensus emerging during arguments that the abortion opponents challenging the FDA's approval lack legal standing to sue. Justices, including conservative appointees, expressed skepticism about the opponents' standing, signaling a potential dismissal of the case. The decision, expected by early summer, could have significant political and practical implications, affecting access to medication abortions and telehealth visits. Abortion rights activists rallied outside the court, and the case's outcome may impact future abortion-related regulations.